1. Home
  2. RVPH vs FATBB Comparison

RVPH vs FATBB Comparison

Compare RVPH & FATBB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVPH
  • FATBB
  • Stock Information
  • Founded
  • RVPH 2006
  • FATBB 2017
  • Country
  • RVPH United States
  • FATBB United States
  • Employees
  • RVPH N/A
  • FATBB N/A
  • Industry
  • RVPH Biotechnology: Pharmaceutical Preparations
  • FATBB Restaurants
  • Sector
  • RVPH Health Care
  • FATBB Consumer Discretionary
  • Exchange
  • RVPH Nasdaq
  • FATBB Nasdaq
  • Market Cap
  • RVPH 88.0M
  • FATBB 71.5M
  • IPO Year
  • RVPH N/A
  • FATBB N/A
  • Fundamental
  • Price
  • RVPH $1.39
  • FATBB $3.44
  • Analyst Decision
  • RVPH Strong Buy
  • FATBB
  • Analyst Count
  • RVPH 5
  • FATBB 0
  • Target Price
  • RVPH $11.40
  • FATBB N/A
  • AVG Volume (30 Days)
  • RVPH 1.4M
  • FATBB 14.5K
  • Earning Date
  • RVPH 04-14-2025
  • FATBB 01-01-0001
  • Dividend Yield
  • RVPH N/A
  • FATBB 16.42%
  • EPS Growth
  • RVPH N/A
  • FATBB N/A
  • EPS
  • RVPH N/A
  • FATBB N/A
  • Revenue
  • RVPH N/A
  • FATBB $606,008,000.00
  • Revenue This Year
  • RVPH N/A
  • FATBB $27.15
  • Revenue Next Year
  • RVPH N/A
  • FATBB $10.38
  • P/E Ratio
  • RVPH N/A
  • FATBB N/A
  • Revenue Growth
  • RVPH N/A
  • FATBB 42.38
  • 52 Week Low
  • RVPH $0.60
  • FATBB $2.62
  • 52 Week High
  • RVPH $4.33
  • FATBB $5.18
  • Technical
  • Relative Strength Index (RSI)
  • RVPH 31.30
  • FATBB 45.40
  • Support Level
  • RVPH $1.36
  • FATBB $3.33
  • Resistance Level
  • RVPH $1.88
  • FATBB $3.85
  • Average True Range (ATR)
  • RVPH 0.15
  • FATBB 0.26
  • MACD
  • RVPH -0.06
  • FATBB -0.12
  • Stochastic Oscillator
  • RVPH 7.59
  • FATBB 15.16

About RVPH Reviva Pharmaceuticals Holdings Inc.

Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, and Parkinson's disease psychosis and its other drug candidate is RP1208.

About FATBB FAT Brands Inc. Class B

FAT Brands Inc is a multi-brand restaurant franchising company. It develops, markets, acquires and manages quick service, fast casual, casual dining, and polished casual dining restaurant concepts around the world. The company operates as a franchisor of restaurants, where the company generally does not own or operate the restaurant locations but rather generates revenue by charging franchisees an initial franchise fee as well as ongoing royalties. For some of the company's brands, it also directly owns and operates restaurant locations. Its brands include Round Table Pizza, Fatburger, Johnny Rockets, Twin Peaks, and Elevation Burger among others. Geographically, the majority of the revenue for the company is generated from the United States and the rest from other countries.

Share on Social Networks: